Neuropeptide Y and dynorphin‐immunoreactive large dense‐core vesicles are strategically localized for presynaptic modulation in the hippocampal formation and substantia nigra

Synapse

Volumn 19, Issue 3, 1995, Pages 160-169

  Pickel, Virginia M ^a   Chan, June ^a   Veznedaroglu, Erol ^a   Milner, Teresa A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Astrocytes; Exocytosis; Kappa receptors; Long term potentiation; Opiate reward; Opioid peptide

Indexed keywords

DYNORPHIN; KAPPA OPIATE RECEPTOR; NEUROPEPTIDE Y; OPIATE PEPTIDE; POSTSYNAPTIC RECEPTOR;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; DENTATE GYRUS; EXOCYTOSIS; HIPPOCAMPUS; LONG TERM POTENTIATION; MEMBRANE VESICLE; MEMORY; NERVE ENDING; NONHUMAN; OPIATE ADDICTION; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMAL; DYNORPHINS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; NEUROPEPTIDE Y; ORGANELLES; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE DISTRIBUTION;

EID: 0028914142     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.890190303     Document Type: Article

References (65)

1. β‐Adrenergic receptors: Astrocytic localization in the adult visual cortex and their relation to catecholamine axon terminals as revealed by electron microscopic immunocytochemistry
2. Neuropeptide Y in cortex and striatum. Ultrastructural distribution and coexistence with classical neurotransmitters and neuropeptides
3. Optimizing release from peptide hormone secretory nerve terminals
4. Technical aspects of opioid receptor localization: Detection of opioid receptor proteins by immunocytochemistry or with a biotinylated dynorphin analog
5. Evidence for a kappaopioid receptor on pituitary astrocytes: An autoradiographic study
6. Isolation and characterization of postsynaptic densities from various brain regions: Enrichment of different types of postsynaptic densities
7. The role of Ca2+ channels in hippocampal mossy fiber synaptic transmission and long‐term potentiation
8. The anatomy of neuropeptide‐Y‐containing neurons in rat brain
9. Neuropeptide Y action in the rat hippocampal slice: Site and mechanism of presynaptic inhibition
10. Calcium‐dependent postsynaptic exocytosis: A possible mechanism for activity‐dependent synaptic modulation
11. A role for postsynaptic neurons in determining presynaptic release properties in the cricket CNS: Evidence for retrograde control of facilitation
12. Neurobiology of opiate abuse
13. Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters
14. The effect of neuropeptides on the release of neurotransmitter amino acids from rat striatum
15. β and kappa opiate receptors in primary astroglial cultures. Part II: Receptor sets in cultures from various brain regions and interactions with β‐receptor activated cyclic AMP
16. 2+ channels
17. Glutamate immunoreactive terminals in the lateral amygdaloid nucleus: a possible substrate for emotional memory
18. Aspartate and glutamate mediate excitatory synaptic transmission in area CA1 of the hippocampus
19. Modulation of memory processing by neuropeptide Y varies with brain injection site
20. 2+ concentration exploring possible bases for a sliding synaptic modification threshold
21. ‘Neurosecretion’ by synaptic terminals in the locust corpus cardiacum: Is non‐synaptic exocytosis part of the regulated or the constitutive pathway?
22. Characterization and presynaptic modulation of stimulation‐evoked exocytotic co‐release of noradrenaline and neuropeptide Y in guinea pig heart
23. Autoradiographic localization of binding sites for neuropeptide Y and bradykinin on astrocytes
24. Use of avidin‐biotin‐peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
25. Synaptic localization of kappa opioid receptors in guinea pig neostriatum
26. Are NPY and enkephalins costored in the same noradrenergic neurons and vesicles
27. GABAergic neurons contain somatostatin‐like immunoreactivity in rat; hippocampus and dentate gyrus
28. Maintenance of glial plasticity with aging in C‐6 glial cells and normal astrocytes in culture: Responsiveness to opioid peptides
29. Role of dynorphin and GABA in the inhibitory regulation of NMDA‐induced dopamine release in striosome‐ and matrix‐enriched areas of the rat striatum
30. Long‐term potentiation is associated with increases in quantal content and quantal amplitude
31. Ca2+ entry via postaynaptic voltage‐sensitive Ca2+ channels can transiently potentiate excitatory synaptic transmission in the hippocampus
32. A novel immunocytochemical model system for specificity and sensitivity screening of antisera against multiple antigens
33. Electron microscopic pre‐embedding double immunostaining methods
34. Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus
35. Mechanisms underlying long‐term potentiation of synaptic transmission
36. Neuropeptide Y receptor binding sites in human brain
37. Quantitative autoradiographic distribution of Bolton‐Hunter neuropeptide Y receptor binding sites in rat brain. Comparison with peptide YY receptor sites
38. Ultrastructural localization of neuropeptide Y‐like immunoreactivity in the rat hippocampal formation
39. The exocytotic fusion pore and neurotransmitter release
40. Is swelling of the secretory granule matrix the force that dilates the exocytotic fusion pore?
41. Ultrastructural localization of neurotensin immunoreactivity in the stellate ganglion of the cat
42. The secretory granule matrix: A fast‐acting smart polymer
43. Diffusion artifacts in 3,3′‐diaminobenzidine cytochemistry
44. GTP gamma S stimulates exocytosis in patch‐clamped rat melanotrophs
45. Beginning of exocytosis captured by rapid‐freezing of Limulus amebocytes
46. The role of Ca2+ entry via synaptically activated NMDA receptors in the induction of long‐term potentiation
47. Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra
48. Glia, neurons, and plasticity
49. Coexistence of GABA and glutamate in mossy fiber terminals of the primate hippocampus: An ultrastructural study
50. A functional role for opioid peptides in the differential secretion of vasopressin and oxytocin
51. Inhibitory effects of the kappa opiate U50, 488 in the substantia nigra pars reticulata
52. Involvement of the nigrotectal and nigrothalamic pathways in kappa opioid‐induced circling
53. 1xocytosis from neuronal large dense‐cored vesicles
54. Glutamate and GABA receptors in vertebrate glial cells
55. Afferent connections of the rat substantia nigra pars lateralis with special reference to peptide‐containing neurons of the amygdalo‐nigral pathway
56. Relationship of Met‐enkephalin‐like immunoreactivity to vagal afferents and motor dendrites in the nucleus of the solitary tract: A. light and electron microscopic dual labeling study
57. Characterization of the release of cholecystokinin‐8 from isolated nerve terminals and comparison with exocytosis of classical transmitters
58. Differential release of amino acids, neuropeptides, and catecholamines from isolated nerve terminals
59. Characterization of the release of Met‐enkephalin from isolated nerve terminals: Release kinetics and cation‐dependence
60. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long‐term potentiation
61. Colocalization of excitatory and inhibitory neurotransmitter markers in striatal projection neurons in the rat
62. Dynorphin‐A‐(1‐8) is contained within vasopressin neurosecretory vesicles in rat pituitary
63. Identification of a subpopulation of neuropeptide Y‐containing locus coeruleus neurons that project to the entorhinal cortex
64. Exocytosis from large dense cored vesicles outside the active synaptic zones of terminals within the trigeminal subnucleus caudalis: A possible mechanism for neuropeptide release